History and exam
Key diagnostic factors
common
hemoglobinuria
Budd-Chiari syndrome
Other diagnostic factors
common
history of aplastic anemia
fatigue
Almost all patients with PNH, regardless of the degree of anemia, have fatigue and listlessness.[1]
anemia
More than 90% of patients with PNH are anemic at presentation. Degree of anemia varies greatly and is accompanied by signs of intravascular hemolysis (increased reticulocyte count, increased serum LDH, low haptoglobin).[18] In descending order, hemolysis, iron deficiency, and concomitant bone marrow hypoplasia contribute to the anemia of PNH patients.
abdominal pain
dysphagia and odynophagia
Difficult or painful swallowing due to increased esophageal contractions. Symptoms worsen during hemolytic episodes.
erectile dysfunction
Almost all men have erectile dysfunction, especially during paroxysms of hemoglobinuria.[9]
dyspnea
Many patients have dyspnea, which may be due to anemia or pulmonary hypertension.[9]
infections
Moderately common due to granulocytopenia.[15]
uncommon
bleeding diathesis
Petechiae, ecchymoses, or frank bleeding (epistaxis, mucosal bleeding, gastrointestinal bleeding, genitourinary bleeding) may occur in the setting of concomitant marrow hypoplasia or myelodysplastic syndrome with low platelet numbers.
neurologic signs and symptoms
Usually related to cerebrovascular thrombotic events. Signs of elevated intracranial pressure (headache/vomiting, papilledema, coma in severe cases) and/or frank sensorimotor deficits according to the affected site.[20]
Risk factors
strong
aplastic anemia/hypoplastic bone marrow
About 50% of patients with aplastic anemia have a clone of paroxysmal nocturnal hemoglobinuria (PNH) cells, predominantly small and asymptomatic.[7] Expansion of the clone, sufficient to cause symptoms, occurs in about 15% of patients with aplastic anemia successfully treated without stem cell transplantations.[12] The reason for the expansion of the clone(s) in these patients is unknown.
The presence of a PNH clone, regardless of its size, has been associated with a favorable response to immunosuppressive therapy (IST) and stem cell transplantation (SCT) in aplastic anemia. Patients with PNH positivity showed higher success rates for IST response and hematopoietic SCT outcomes compared with those without PNH. Additionally, PNH positivity had a beneficial impact on clonal evolution.[13]
All patients with PNH have a degree of marrow hypoplasia, often detected only by marrow culture studies.[14] Patients with classic PNH may have bone marrow failure as a late event.[15]
weak
myelodysplasia
Small PNH clones have been described in patients with low-risk myelodysplasia, particularly refractory anemia with a hypoplastic marrow. Clinical PNH arises in a few of these patients.[16][17] The presence of a PNH clone, regardless of its size, has been associated with a favorable response to IST and stem cell transplantation in myelodysplastic syndromes.[13]
Use of this content is subject to our disclaimer